We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+18.68%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.69B
AUM Growth
+$682M
Cap. Flow
-$395M
Cap. Flow %
-5.9%
Top 10 Hldgs %
54.02%
Holding
678
New
246
Increased
85
Reduced
72
Closed
235

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$85.8M
2
INDV icon
Indivior Pharmaceuticals
INDV
+$59.6M
3
BCAX
Bicara Therapeutics
BCAX
+$45.8M
4
MRUS
Merus
MRUS
+$34.4M
5
VTRS icon
Viatris
VTRS
+$30M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$102M
2
SGRY icon
Surgery Partners
SGRY
+$86.4M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$53.7M
4
IART icon
Integra LifeSciences
IART
+$42.8M
5
BNTX icon
BioNTech
BNTX
+$38.6M

Sector Composition

Rank Sector Weight
1 Healthcare 87.45%
2 Industrials 0.73%
3 Technology 0.55%
4 Financials 0.45%
5 Consumer Discretionary 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABSI icon
126
Absci
ABSI
$1.28B
$1.01M 0.02%
265,382
+82,289
+45% +$327K
NUS icon
127
Nu Skin
NUS
$250M
$1.01M 0.02%
137,145
+123,692
+919% +$1.16M
BBDC icon
128
Barings BDC
BBDC
$868M
$1M 0.01%
102,058
+85,288
+509% +$847K
UPBD icon
129
Upbound Group
UPBD
$1.2B
$992K 0.01%
+31,004
New +$996K
EYE icon
130
National Vision
EYE
$1.66B
$983K 0.01%
+90,091
New +$1.05M
GPN icon
131
Global Payments
GPN
$23B
$981K 0.01%
+9,580
New +$994K
WAFD icon
132
WaFd
WAFD
$2.69B
$976K 0.01%
+28,005
New +$953K
NTNX icon
133
Nutanix
NTNX
$15.4B
$973K 0.01%
16,429
+2,222
+16% +$122K
AMED
134
DELISTED
Amedisys
AMED
$972K 0.01%
+10,072
New +$983K
KLIC icon
135
Kulicke & Soffa
KLIC
$5.14B
$972K 0.01%
+21,531
New +$952K
XEL icon
136
Xcel Energy
XEL
$50.4B
$965K 0.01%
+14,782
New +$877K
HQY icon
137
HealthEquity
HQY
$8.28B
$964K 0.01%
+11,781
New +$909K
CDNA icon
138
CareDx
CDNA
$1.88B
$964K 0.01%
+30,871
New +$768K
MRK icon
139
Merck
MRK
$323B
$963K 0.01%
+8,482
New +$1.01M
BANC icon
140
Banc of California
BANC
$3.21B
$960K 0.01%
+65,140
New +$904K
ZS icon
141
Zscaler
ZS
$23.8B
$957K 0.01%
+5,600
New +$1.02M
HLIO icon
142
Helios Technologies
HLIO
$2.59B
$954K 0.01%
+19,995
New +$879K
PPBI
143
DELISTED
Pacific Premier Bancorp
PPBI
$949K 0.01%
+37,705
New +$941K
GRC icon
144
Gorman-Rupp
GRC
$2.13B
$945K 0.01%
+24,253
New +$931K
ADBE icon
145
Adobe
ADBE
$94.5B
$944K 0.01%
1,823
-137
-7% -$75.1K
COF icon
146
Capital One
COF
$127B
$942K 0.01%
+6,291
New +$896K
ADMA icon
147
ADMA Biologics
ADMA
$1.97B
$940K 0.01%
47,016
-12,204
-21% -$190K
CRS icon
148
Carpenter Technology
CRS
$28.8B
$936K 0.01%
+5,864
New +$794K
ALG icon
149
Alamo Group
ALG
$2B
$927K 0.01%
+5,148
New +$918K
PETQ
150
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$926K 0.01%
+30,082
New +$813K
4 5
6
7 8

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2024 Portfolio in Review

As of Q3 2024, Deerfield Management held 678 positions worth $6.69B, up 11% from $6.01B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $395M in Q3 2024, closing 235 positions and reducing 72 holdings. Its most notable exit was Gilead Sciences, an estimated $102M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 83% a quarter earlier, followed by Industrials and Technology.

Against the trend, Deerfield Management opened a new position in Indivior Pharmaceuticals worth $49.7M.

  • Deerfield Management's largest Q3 2024 buy was Indivior Pharmaceuticals: 5,092,642 shares worth $49.7M.
  • Deerfield Management added most to Neurocrine Biosciences in Q3 2024, an estimated $85.8M increase.
  • Deerfield Management's biggest Q3 2024 reduction was Surgery Partners, cutting an estimated $86.4M.
  • Deerfield Management fully exited Gilead Sciences in Q3 2024, selling an estimated $102M.
  • Deerfield Management's ten largest holdings make up 54% of its $6.69B portfolio in Q3 2024.
  • Deerfield Management opened 246 new positions and closed 235 in Q3 2024.
  • Deerfield Management's portfolio value rose 11% quarter-over-quarter to $6.69B.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.